作者：
Sascha,Dietrich [1]
;
Jennifer,Hüllein [2]
;
Stanley Chun-Wei,Lee [3]
;
Barbara,Hutter [4]
;
David,Gonzalez [5]
;
Sandrine,Jayne [6]
;
Martin J S,Dyer [6]
;
Małgorzata,Oleś [7]
;
Monica,Else [8]
;
Xiyang,Liu [2]
;
Mikołaj,Słabicki [2]
;
Bian,Wu [2]
;
Xavier,Troussard [9]
;
Jan,Dürig [10]
;
Mindaugas,Andrulis [11]
;
Claire,Dearden [12]
;
Christof,von Kalle [13]
;
Martin,Granzow [14]
;
Anna,Jauch [14]
;
Stefan,Fröhling [2]
;
Wolfgang,Huber [7]
;
Manja,Meggendorfer [15]
;
Torsten,Haferlach [15]
;
Anthony D,Ho [16]
;
Daniela,Richter [2]
;
Benedikt,Brors [4]
;
Hanno,Glimm [2]
;
Estella,Matutes [12]
;
Omar,Abdel Wahab [3]
;
Thorsten,Zenz [17]
作者单位：
Department of Medicine V, University Hospital Heidelberg, Genome Biology Unit, European Molecular Biology Laboratory, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
[1]
Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
[2]
Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
[3]
Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
[4]
Centre for Molecular Pathology, Royal Marsden NHS Foundation Trust, London, United Kingdom;
[5]
Ernest and Helen Scott Hematological Research Institute, University of Leicester, Leicester, United Kingdom;
[6]
Genome Biology Unit, European Molecular Biology Laboratory, and.
[7]
Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;
[8]
Laboratoire d'Hématologie, CHU Côte de Nacre, Caen, France;
[9]
Department of Hematology, University Hospital, Essen, Germany;
[10]
Department of General Pathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany;
[11]
Royal Marsden Hospital, London, United Kingdom;
[12]
Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg, Germany;
[13]
Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany; and.
[14]
Munich Leukemia Laboratory, Munich, Germany.
[15]
Department of Medicine V, University Hospital Heidelberg.
[16]
Department of Medicine V, University Hospital Heidelberg, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
[17]
DOI
10.1182/blood-2015-04-643361
PMID
26065650
发布时间
2022-03-10
换一批
换一批
